dexamethasone suppression test , DST (Abkürzung)

In reality this test is performed following a Low dose dexamethasone suppression test.

Bulimia related to affective disorder by family history and response to the dexamethasone suppression test.

Urinary free cortisol and response to the dexamethasone suppression test in bulimia: a pilot study.

Learn about the purpose of Dexamethasone Suppression Test, what to expect and how to prepare for this test.

High-dose dexamethasone suppression test: A test in which one or more high doses of dexamethasone is given.

The functionality of the HPA can be assessed by dexamethasone suppression test .

Doctors can use an overnight dexamethasone suppression test to screen for Cushing's syndrome, a condition in which the adrenal glands produce too much cortisol.

The dexamethasone suppression test is designed to diagnose and differentiate among the various types of Cushing's syndrome and other hypercortisol states.

Procedure under taken include CRH testing,dexamethasone suppression test, Synacthen test.

The overnight dexamethasone suppression test checks to see how taking a corticosteroid medicine (called dexamethasone) changes the levels of the hormone cortisol in the blood.

An overnight dexamethasone suppression test is done to check for a condition in which large amounts of cortisol are produced by the adrenal glands (Cushing's syndrome).

In these cases, a dexamethasone suppression test is often used to detect cortisol excess, and metanephrines or catecholamines for excess of these hormones.

Patients presenting with clinical signs of glucocorticoid excess (Cushing's syndrome) are generally diagnosed by a 24-hour urine collection for cortisol or by a dexamethasone suppression test.

Individuals diagnosed with PTSD respond more strongly to a dexamethasone suppression test than individuals diagnosed with clinical depression.

Dexamethasone Suppression Test Dexamethasone Suppression Test information at HowStuffWorks.

The HPA axis appears to be dysregulated in psychotic depression, with dexamethasone suppression tests demonstrating higher levels of cortisol following dexamethasone administration (i.e. lower cortisol suppression).

Diagnosis is made first by diagnosis of Cushing's Syndrome which can include salivary and blood serum cortisol testing, 24-hour urinary free cortisol testing, and the dexamethasone suppression test.

Following the 8 mg dexamethasone suppression test plasma cortisol should be low; while plasma ACTH should be at the higher end of normal or should exceed the reference range.

A dexamethasone suppression test (DST) and plasma and urine methoxyhydroxyphenylglycol (MHPG) test can be used to estimate who is likely to respond to moclobemide antidepressant therapy.

When Cushing's syndrome is suspected, either a dexamethasone suppression test (administration of dexamethasone and frequent determination of cortisol and ACTH level), or a 24-hour urinary measurement for cortisol offer equal detection rates.

Also, a baseline pituitary hormonal function test should be done, including measurements of serum levels of TSH, prolactin, IGF-1 (as a test of growth hormone activity), adrenal function (i.e. 24 hour urine cortisol, dexamethasone suppression test), testosterone in men, and estradiol in amenorrheic women.